Biophytis unveils design for obesity study - Marketscreener.com

BPTSDelisted Stock  USD 7.03  0.00  0.00%   
Slightly above 56% of Biophytis' investor base is looking to short. The analysis of current outlook of investing in Biophytis suggests that many traders are alarmed regarding Biophytis' prospects. Biophytis' investing sentiment can be driven by a variety of factors including economic data, Biophytis' earnings reports, geopolitical events, and overall market trends.
  
Biophytis unveils design for obesity study Marketscreener.com

Read at news.google.com
Google News at Macroaxis
  

Biophytis Fundamental Analysis

We analyze Biophytis' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biophytis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biophytis based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Total Asset

Total Asset Comparative Analysis

Biophytis is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Biophytis Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biophytis stock to make a market-neutral strategy. Peer analysis of Biophytis could also be used in its relative valuation, which is a method of valuing Biophytis by comparing valuation metrics with similar companies.

Peers

Biophytis Related Equities

NRXPNRX Pharmaceuticals   0.84   
0%
4.0%
ANEBAnebulo Pharmaceuticals   0.72   
0%
3.0%
XOMAOXOMA   0.51   
0%
2.0%
AKTXAkari Therapeutics   0.31   
0%
1.0%
RZLTRezolute   0.22   
0%
1.0%
CHRSCoherus BioSciences   0.00   
0%
0%
ARMPArmata Pharmaceuticals   0.00   
0%
0%
BOLTBolt Biotherapeutics   0.38   
2.0%
0%
HCWBHCW Biologics   0.83   
4.0%
0%
INBXInhibrx   0.88   
4.0%
0%
TPSTTempest Therapeutics   0.93   
5.0%
0%
PTIXProtagenic Therapeutics   1.00   
5.0%
0%
SPROSpero Therapeutics   2.73   
14.0%
0%
PCSAProcessa Pharmaceuticals   6.31   
34.0%
0%
IPHAInnate Pharma   18.54   
100.0%
0%
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Consideration for investing in Biophytis Stock

If you are still planning to invest in Biophytis check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biophytis' history and understand the potential risks before investing.
CEOs Directory
Screen CEOs from public companies around the world
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Bonds Directory
Find actively traded corporate debentures issued by US companies
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets